ARTERIAL STIFFNESS ASSESSMENT IN ABDOMINALLY OBESE INDIVIDUALS: INSIGHTS FROM CLINICAL OBESITY PHENOTYPES

Authors

  • Ovidiu MITU ‟Grigore Popa” University of Medicine and Pharmacy Iași
  • R. S. MIFTODE ‟Grigore Popa” University of Medicine and Pharmacy Iași
  • F. MITU ‟Grigore Popa” University of Medicine and Pharmacy Iași
  • Manuela CIOCOIU ‟Grigore Popa” University of Medicine and Pharmacy Iași
  • Ivona MITU ‟Grigore Popa” University of Medicine and Pharmacy Iași

DOI:

https://doi.org/10.22551/yvtn4902

Abstract

Precise cardiovascular risk assessment remains challenging, especially amidst the dynamic interplay of factors like abdominal obesity, inadequate physical activity and imbalanced diet. This study aims to assess subclinical atherosclerosis in apparently healthy individuals with excess weight, using arterial stiffness as a parameter for cardiovascular risk assessment. Materials and methods: A cohort of 67 patients aged 35-75 years, without any prior atherosclerotic pathology, with abdominal obesity and no known chronic illnesses, underwent evaluation. The cohort was stratified based on obesity (BMI≥30kg/m2), metabolic syndrome (MetS NCEP-ATP III criteria), BMI class, total or trunk adipose tissue percentage, and clinical phenotypes of obesity (metabolically healthy obese - MHO, metabolically unhealthy obese - MUO, metabolically healthy non-obese - MHNO, metabolically unhealthy non-obese - MUNO), where unhealthy is defined by the presence of MetS. Biochemical analysis was performed to assess glucose, TG and HDL-c levels, aiming to detect potential undiagnosed cases of MetS. Adiponectin and leptin measurements were also performed. Hologic QDR Delphi A determined whole body composition with dual-energy-X-ray absorptiometry (DEXA) and Arteriograph® Tensiomed measured parameters of subclinical atherosclerosis. Results: Pulse wave velocity (PWV) values did not significantly differ across study groups, including obese versus non-obese individuals, clinical phenotypes of obesity, presence or absence of MetS, groups defined by BMI class, or adipose tissue percentages. Nevertheless, participants with excess weight or with MetS presented lower AIXa values. The groups that did not present MetS (obese and non-obese) showed the highest proportion of patients with PWV values under the age-adjusted theoretical threshold (46.15% and 44.4%, respectively), suggesting a potentially lower vascular age than the biological one. Conversely, the groups with MetS (obese and non-obese) had smaller percentages (26.67% and 16.66%, respectively). Around 30% of patients across clinical obesity phenotypes exhibited PWV values exceeding the theoretical threshold, but under 10 m/s. Conclusions: AIXa values are lower in the presence of MetS and in higher BMI subjects, whereas PWV values do not change significantly. Healthy obese individuals demonstrate a vascular age similar to the healthy non-obese group, suggesting enhanced cardiovascular protection. On the other hand, arterial stiffness is reported in a higher percentage of subjects that present MetS (obese or non-obese) compared to subjects without MetS, even though the syndrome is at an early stage.

Author Biographies

  • Ovidiu MITU, ‟Grigore Popa” University of Medicine and Pharmacy Iași

    Faculty of Medicine
    Department of Medical Specialties (I) 

  • R. S. MIFTODE, ‟Grigore Popa” University of Medicine and Pharmacy Iași

    Faculty of Medicine
    Department of Medical Specialties (I) 

  • F. MITU, ‟Grigore Popa” University of Medicine and Pharmacy Iași

    Faculty of Medicine
    Department of Medical Specialties (I)

  • Manuela CIOCOIU, ‟Grigore Popa” University of Medicine and Pharmacy Iași

    Faculty of Medicine
    Department of Morpho-Functional Sciences (II)

  • Ivona MITU, ‟Grigore Popa” University of Medicine and Pharmacy Iași

    Faculty of Medicine
    Department of Morpho-Functional Sciences (II)

References

1. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR; ACCT Investigators. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 2005; 46(9): 1753-1760 / doi: 10.1016/j.jacc. 2005. 07.037.

2. Jain S, Khera R, Corrales-Medina VF, Townsend RR, Chirinos JA. Inflammation and arterial stiffness in humans. Atherosclerosis 2014; 237(2): 381-390 / doi: 10.1016/ j.atherosclerosis.2014.09.011.

3. Eikås JG, Gerdts E, Halland H, Midtbø H, Cramariuc D, Kringeland E. Arterial Stiffness in Over-weight and Obesity: Association with Sex, Age, and Blood Pressure. High Blood Press Cardiovasc Prev 2023; 30(5): 435-443 / doi: 10.1007/s40292-023-00593-2.

4. Corrigan FE 3rd, Kelli HM, Dhindsa DS, et al. Changes in truncal obesity and fat distribution predict arterial health. J Clin Lipidol 2017; 11(6): 1354-1360 / doi: 10.1016/ j.jacl.2017.08.013.

5. Strasser B, Arvandi M, Pasha EP, Haley AP, Stanforth P, Tanaka H. Abdominal obesity is associated with arterial stiffness in middle-aged adults. Nutr Metab Cardiovasc Dis 2015; 25(5): 495-502 / doi: 10.1016/j.numecd.2015.01.002.

6. Kim S, Kyung C, Park JS, et al. Normal-weight obesity is associated with increased risk of subclinical atherosclerosis. Cardiovasc Diabetol 2015; 14: 58 / doi: 10.1186/ s12933-015-0220-5.

7. Lalazar G. Central obesity: Redefining normal BMI. Sci Transl Med 2015; 7: 316ec209.

8. Tutor AW, Lavie CJ, Kachur S, Milani RV, Ventura HO. Updates on obesity and the obesity paradox in cardiovascular diseases. Prog Cardiovasc Dis 2023; 78: 2-10 / doi: 10.1016/j. pcad.2022.11.013.

9. Antonopoulos AS, Tousoulis D. The molecular mechanisms of obesity paradox. Cardiovasc Res 2017; 113(9): 1074-1086 / doi: 10.1093/cvr/cvx106.

10. Patel N, Elsaid O, Shenoy A, Sharma A, McFarlane SI. Obesity paradox in patients undergoing coro-nary intervention: A review. World J Cardiol 2017; 9(9): 731-736 / doi: 10. 4330/wjc.v9.i9.731.

11. Biasucci LM, Graziani F, Rizzello V, et al. Paradoxical preservation of vascular function in severe obesity. Am J Med. 2010 Aug; 123(8): 727-734 / doi: 10.1016/j.amjmed.2010.02.016.

12. Horváth IG, Németh Á, Lenkey Z, et al. Invasive validation of a new oscillometric device (Arterio-graph) for measuring augmentation index, central blood pressure and aortic pulse wave velocity. J Hypertens 2010; 28(10): 2068-2075.

13. Tensiomed. Innovative Method to Ease Arterial Stiffness Measurement.

https: //www.tensiomed.com. Accessed 4th February 2025.

14. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112(17): 2735-2752.

15. Willum Hansen T, Staessen JA, Torp-Pedersen C, et al. Prognostic Value of Aortic Pulse Wave Ve-locity as Index of Arterial Stiffness in the General Population. Circulation 2006; 113(5): 664-670.

16. van Trijp MJCA, Uiterwaal CSPM, Bos WJW, et al. Noninvasive Arterial Measurements of Vascular Damage in Healthy Young Adults: Relation to Coronary Heart Disease Risk. Ann Epidemiol 2006; 16(2): 71-77.

17. van Trijp MJCA, Bos WJW, van der Schouw YT, et al. Non-invasively measured structural and functional arterial characteristics and coronary heart disease risk in middle aged and elderly men. Atherosclerosis 2006; 187(1): 110-115.

18. Ounis-Skali N, Bentley-Lewis R, Mitchell GF, et al. Central aortic pulsatile hemodynamics in obese premenopausal women. Journal of the American Society of Hypertension 2007; 1(5): 341-346.

19. Maple-Brown LJ, Piers LS, O’Rourke MF, et al. Central obesity is associated with reduced peripheral wave reflection in Indigenous Australians irrespective of diabetes status. J Hypertens 2005; 23(7): 1403-1407.

20. Otsuka T, Kawada T, Ibuki C, Kusama Y. Obesity as an independent influential factor for reduced radial arterial wave reflection in a middle-aged Japanese male population. Hypertension Research 2009; 32(5): 387-391.

21. Li P, Wang L, Liu C. Overweightness, obesity and arterial stiffness in healthy subjects: a systematic review and meta-analysis of literature studies. Postgrad Med 2017; 129(2): 224-230 / doi: 10.1080/ 00 325481.2017.1268903.

22. Gurm HS, Brennan DM, Booth J, et al. Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox). Am J Cardiol 2002; 90: 42-45.

23. Farb MG, Gokce N. Visceral adiposopathy: a vascular perspective. Horm Mol Biol Clin Investig 2015; 21(2): 125-136.

24. Baron AD, Brechtel-Hook G, Johnson A, et al. Effect of perfusion rate on the time course of insulin-mediated skeletal muscle glucose uptake. American Journal of Physiology- Endocrinology and Me-tabolism 1996; 271(6): E1067-1072.

25. Tamminen M, Westerbacka J, Vehkavaara S, Yki-Järvinen H. Insulin-Induced Decreases in Aortic Wave Reflection and Central Systolic Pressure Are Impaired in Type 2 Diabetes. Diabetes Care 2002; 25(12): 2314-2319.

26. Jahn LA, Hartline L, Rao N, et al. Insulin Enhances Endothelial Function Throughout the Arterial Tree in Healthy but not Metabolic Syndrome Subjects. J Clin Endocrinol Metab 2016; 101(3): 1198-1206.

27. Lee JW, Lee DC, Im JA, et al. Insulin Resistance Is Associated with Arterial Stiffness Independent of Obesity in Male Adolescents. Hypertension Research 2007; 30(1): 5-11.

28. Dotson BL, Heiston EM, Miller SL, Malin SK. Insulin stimulation reduces aortic wave reflection in adults with metabolic syndrome. American Journal of Physiology-Heart and Circulatory Physiology 2021; 320(6): H2305-312.

29. Airaksinen KEJ, Salmela PI, Linnaluoto MK, et al. Diminished arterial elasticity in diabetes: association with fluorescent advanced glycosylation end products in collagen. Cardiovasc Res 1993; 27(6): 942-945.

30. Begum N, Song Y, Rienzie J, Ragolia L. Vascular smooth muscle cell growth and insulin regulation of mitogen-activated protein kinase in hypertension. American Journal of Physiology-Cell Physiology 1998; 275(1): C42-49.

31. Desamericq G, Tissot CM, Akakpo S, et al. Carotid-Femoral Pulse Wave Velocity Is Not Increased in Obesity. Am J Hypertens 2015; 28(4): 546-851.

32. Phillips J, McBride CA, Morris E, et al. Adiposity, but not Obesity, Is Associated With Arterial Stiff-ness in Young Nulliparous Women. Reproductive Sciences 2018; 25(6): 909-915.

33. Topouchian J, Labat C, Gautier S, et al. Effects of metabolic syndrome on arterial function in different age groups. J Hypertens. 2018; 36(4): 824-833.

34. Nedogoda SV, Salasyuk AS, Barykina IN, et al. Identifying Early Vascular Ageing in Patients with Metabolic Syndrome: Unresolved Issues and a Proposed Novel VAmets Score. Heart Lung Circ 2021; 30(11): 1752-1761.

35. el Khoudary SR, Barinas-Mitchell E, White J, et al. Adiponectin, systolic blood pressure, and alcohol consumption are associated with more aortic stiffness progression among apparently healthy men. Atherosclerosis 2012; 225(2): 475-480.

36. Bielecka-Dabrowa A, Bartlomiejczyk MA, Sakowicz A, et al. The Role of Adipokines in the Devel-opment of Arterial Stiffness and Hypertension. Angiology 2020; 71(8): 754-761.

37. Eckel N, Li Y, Kuxhaus O, et al. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses’ Health Study): 30-year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol 2018; 6(9): 714-724.

38. Blüher M. The myth of innocent obesity. Nat Rev Endocrinol 2017; 13(12): 691-692.

39. Yuan Y, Mu JJ, Chu C, et al. Effect of metabolically healthy obesity on the development of arterial stiffness: a prospective cohort study. Nutr Metab (Lond) 2020; 17(1): 50.

Additional Files

Published

2025-04-07

Issue

Section

INTERNAL MEDICINE - PEDIATRICS